- Beats on the top and bottom line in its Q3 2022 financial results have propelled Medpace Holdings ( NASDAQ: MEDP ) shares 20% higher in after-hours trading.
- Net income in the quarter rose ~36% compared to the prior-year period to $66M ($2.05 EPS diluted vs. $1.29 EPS diluted).
- Revenue of ~$384M was a ~30% year-over-year increase.
- Medpace ( MEDP ) ended the quarter with just $31M in cash, a drastic reduction from the $461.3M on Dec. 31, 2021.
- For full year 2022, GAAP net income is expected in the range of $232M-$236M, with diluted EPS in the range of $6.88-$7.00.
- Seeking Alpha's Quant Rating views Medpace ( MEDP ) as a hold with high marks for revisions and profitability .
For further details see:
Medpace up 20% in after-hours trading after Q3 earnings beats